2
Dec

NICE recommends new lung cancer drug pembrolizumab

Hundreds of people with advanced lung cancer will now have access to new drug pembrolizumab, viagra sale also known as Keytruda, seek after NICE recommends it for routine NHS use.

Pembrolizumab works by targeting a specific protein on the surface of cells which is involved in the body’s immune response to cancer.

In draft guidance NICE has said that adults with advanced lung cancer, vialis 40mg that test positive for this protein, should have access to pembrolizumab.

Professor Carole Longson, director of the NICE centre for health technology evaluation said: “People with advanced non-small-cell lung cancer have had limited treatment options so it is great that pembrolizumab will now be routinely available. The company put forward a fairly priced proposal that reflected the benefits their drug offered.

Read Full Article Here >>